OHRP Ohr Pharmaceutical Inc.

2.27
+0.04  (+2%)
Previous Close 2.23
Open 2.23
Price To Book 0.64
Market Cap 6431729
Shares 2,829,248
Volume 72,099
Short Ratio
Av. Daily Volume 238,933

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data released January 5, 2017 - primary endpoint not met.
OHR-102 (MAKO)
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Phase 2 data released July 2015
OHR-102
Retinal vein occlusion (CRVO)

Latest News

  1. Rigrodsky & Long, P.A. Files Class Action Suit Against Ohr Pharmaceutical, Inc.
  2. NeuBase Therapeutics Announces Agreements for $9 Million Financing
  3. Four Tech Stocks To Watch on Wednesday
  4. Ohr Pharmaceutical Regains Compliance with NASDAQ Listing Requirements
  5. Ohr Pharmaceutical Reports Financial Results for the Fiscal First Quarter of 2019
  6. Lifshitz & Miller LLP Announces Investigation of CAS Medical Systems, Inc., Entegra Financial Corp., Fidelity Southern Corporation, First Data Corporation, Kinderhook Bank Corp., Maxwell Technologies, Inc., Ohr Pharmaceutical, Inc., and Owens Realty Mortgage, Inc.
  7. OHR PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Ohr Pharmaceutical, Inc. - OHRP
  8. The Daily Biotech Pulse: Partial Clinical Hold On Advaxis Cervical Cancer Drug, Ohr's Reverse Split, Ironwood Starts Phase 1 Trial
  9. Ohr Pharmaceutical Announces Reverse Stock Split to be Effective February 4, 2019
  10. INVESTOR ALERT: Monteverde & Associates PC is Investigating the Recently Announced Merger
  11. SHAREHOLDER ALERT: WeissLaw LLP Investigates Ohr Pharmaceutical, Inc.
  12. OHR PHARMACEUTICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Ohr Pharmaceutical, Inc. - OHRP
  13. OHR PHARMACEUTICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger
  14. Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of OHR Pharmaceutical, Inc. (OHRP) on Behalf of Stockholders and Encourages OHRP Investors to Contact the Firm
  15. Here's more about what could be Pittsburgh's next public company
  16. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Ohr Pharmaceutical, Inc. to NeuBase Therapeutics, Inc. is Fair to Shareholders
  17. LifeX Announces Portfolio Company NeuBase Therapeutics To Merge with Ohr Pharmaceutical
  18. 4 Healthcare Stocks Gaining Speed on Thursday (1/3/19)
  19. Ohr Pharmaceutical, Inc. Announces Merger Agreement with NeuBase Therapeutics, Inc.
  20. Investor Expectations to Drive Momentum within Ocean Bio-Chem, Gaming Partners International, Pershing Gold, OHA Investment, Ohr Pharmaceuticals, and J. W. Mays — Discovering Underlying Factors of Influence